Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1241800 | 0.92 | TSHR (0.48) | TSHRALDH1A1LMNATRPA1ABCC4 | |
| SCHEMBL29236761 | 0.89 | TSHR (0.52) | TSHRALDH1A1LMNATRPA1ABCC4 | |
| SCHEMBL29236617 | 0.89 | TSHR (0.52) | TSHRALDH1A1LMNATRPA1ABCC4 | |
| SCHEMBL30890195 | 0.89 | TSHR (0.52) | TSHRALDH1A1LMNATRPA1ABCC4 | |
| SCHEMBL3673730 | 0.82 | — | — | |
| SCHEMBL2954862 | 0.82 | TSHR (0.48) | TSHRALDH1A1LMNATRPA1ABCC4 | |
| SCHEMBL235272 | 0.81 | TSHR (0.42) | TSHRALDH1A1 | |
| SCHEMBL4610326 | 0.81 | TSHR (0.70) | TSHRALDH1A1ABCC4MAPT | |
| SCHEMBL6063997 | 0.79 | TSHR (0.52) | TSHRALDH1A1 | |
| SCHEMBL16243604 | 0.79 | TSHR (0.43) | TSHRALDH1A1LMNATRPA1ABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684341-A | Double-ended organoaluminum compositions | 陶氏环球技术有限责任公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4435013-A2 | PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING | Dow Global Technologies LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-3519474-B1 | PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-3519456-B1 | CAPPED MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3732211-B1 | CAPPED DUAL-HEADED ORGANOALUMINUM COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-111433235-B | Capped double-ended organoaluminum compositions | 陶氏环球技术有限责任公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-109952324-B | Blocked multi-or double-headed compositions suitable for chain shuttling and methods of making the same | 陶氏环球技术有限责任公司 | 2023-06-09 | — | — | CN | disclosed |
| US-11613600-B2 | Capped dual-headed organoaluminum compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-03-28 | — | — | US | disclosed |
| US-11492450-B2 | Dual-headed organoaluminum compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-11-08 | — | — | US | disclosed |
| US-11359038-B2 | Capped multi- or dual-headed compositions useful for chain shuttling and process to prepare the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-14 | — | — | US | disclosed |
| EP-3243846-A2 | MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | Dow Global Technologies Llc (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-2450361-B1 | ORGANOMETALLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | MITSUI CHEMICALS INC (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-2459598-B1 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-18 | — | — | EP | disclosed |
| US-8791284-B2 | Organometallic compound and production method thereof | MITSUI CHEMICALS, INC. (JP) | 2014-07-29 | — | — | US | disclosed |
| US-8501885-B2 | Dual- or multi-headed chain shuttling agents and their use for preparation of block copolymers | DOW GLOBAL TECHNOLOGIES, LLC (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120165486-A1 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-06-28 | — | — | US | disclosed |
| EP-2459598-A2 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | Dow Global Technologies LLC (US) | 2012-06-06 | — | — | EP | disclosed |
| EP-2450361-A1 | ORGANOMETALLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | Mitsui Chemicals, Inc. (JP) | 2012-05-09 | — | — | EP | disclosed |
| US-20120101289-A1 | ORGANOMETALLIC COMPOUND AND PRODUCTION METHOD THEREOF | MITSUI CHEMICALS, INC. | 2012-04-26 | — | — | US | disclosed |
| WO-2011016991-A2 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11613600-B2 | Capped dual-headed organoaluminum compositions | CAPG, C5, CDS2 | TSHR 4645/4885ALDH1A1 2097/4885LMNA 4667/4885 |
| US-20120165486-A1 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR PREPARATION OF BLOCK COPOLYMERS | MSN, COASY, MCM7 | TSHR 4812/4885ALDH1A1 3614/4885LMNA 3625/4885 |
| US-20120101289-A1 | ORGANOMETALLIC COMPOUND AND PRODUCTION METHOD THEREOF | SLC39A11, AP2M1, AP1M1 | TSHR 3613/4885ALDH1A1 1493/4885LMNA 4509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.